Tops & Flops Stocks
| Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Laboratorio Reig Jofre S.A. | 4.980% | -1.509% | -4.396% | 4.819% | 18.100% | -44.586% | 18.100% |
| INSYS Therapeutics Inc | 5.000% | - | - | - | - | - | - |
| Minerva Neurosciences Inc. | 5.000% | 3.333% | -15.068% | -66.166% | -57.498% | -80.204% | - |
| Eidos Therapeutics | 5.050% | - | - | - | - | - | - |
| Pacific Biosciences of California Inc. | 5.080% | -12.473% | -38.334% | -86.784% | -87.052% | -95.248% | -75.912% |
| Aspen Pharmacare | 5.170% | -0.847% | -0.847% | 27.869% | 18.782% | 5.405% | 177.976% |
| Quipt Home Medical Corp. | 5.260% | - | - | - | - | - | - |
| Vical Inc. | 5.300% | - | - | - | - | - | - |
| Nymox Pharmaceutical Corp. | 5.410% | - | - | - | - | - | - |
| Nanorepro AG | 5.420% | -2.895% | 1.653% | -19.079% | -10.437% | -82.725% | 84.500% |
| Champions Oncology Inc | 5.530% | -0.500% | -9.132% | -34.215% | -17.427% | -53.988% | - |
| Adocia | 5.530% | 5.373% | -5.590% | -59.140% | -48.299% | -31.609% | -48.822% |
| Actinium Pharmaceuticals Inc. | 5.700% | -10.756% | -76.602% | -70.158% | -62.367% | -66.971% | -74.110% |
| Shl Telemedicine Ltd | 5.760% | - | - | - | - | - | - |
| Mdxhealth | 5.760% | - | - | - | - | - | - |
| Oncimmune Holdings PLC | 6.320% | 3.261% | 69.643% | -22.131% | -28.571% | -90.452% | -79.121% |
| Thermogenesis Holdings Inc. | 6.330% | - | - | - | - | - | - |
| Hansa Medical AB | 6.610% | 4.369% | 20.183% | 20.874% | 71.452% | -64.776% | -72.612% |
| AquaBounty Technologies Inc | 6.640% | - | - | - | - | - | - |
| Energizer Holdings Inc | 6.670% | 2.273% | -4.255% | -14.557% | -5.594% | -18.182% | -15.519% |
| Seaspine Holdings Corp | 6.670% | - | - | - | - | - | - |
| Alphatec Holdings Inc | 6.860% | 0.000% | -47.959% | -61.940% | -62.774% | -52.336% | 3.701% |
| Athersys Inc. | 6.990% | - | - | - | - | - | - |
| Synairgen plc | 7.040% | 1.429% | -31.068% | -62.113% | -45.300% | -98.016% | -60.556% |
| Canopy Growth Corp | 7.100% | - | - | - | - | - | - |